HS-729 Cells

The HS-729 cell line, originating from human bone and associated with embryonal rhabdomyosarcoma, serves as a critical tool in cancer research. This cell line is derived from a highly malignant and aggressive form of cancer that primarily affects skeletal muscle tissue, often in pediatric patients. The study of HS-729 cells allows researchers to delve into the molecular mechanisms and genetic alterations that drive the development and progression of embryonal rhabdomyosarcoma. Such insights are invaluable for the identification of potential therapeutic targets and the development of novel treatment strategies. HS-729 cells exhibit characteristics typical of rhabdomyosarcoma, including expression of muscle-specific markers and a propensity for rapid proliferation. They provide a model system for testing the efficacy of anti-cancer drugs and understanding drug resistance mechanisms. Additionally, HS-729 cells are instrumental in the study of tumor microenvironment interactions, metastatic behavior, and the role of various signaling pathways in cancer progression. Despite the limited specific information available about HS-729, cell lines of this nature remain indispensable in the ongoing battle against cancer, offering hope for more effective and targeted treatments in the future. Bone cancer cell lines, Bone, Embryonal rhabdomyosarcoma, Growth Conditions: Monolayer, adherent, Biosafety level: BSL 1